Trial intelligence / Profile preview

Gadolinium Contrast Agents and Breath-holding Capacity

NCT02431598Phase 4Completed

Sponsor
Duke University
Start
Jun 2015
Primary completion
Sep 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of gadoxetate disodium, sponsored by Duke University. Started Jun 2015; status: completed.

02

Drugs

gadoxetate disodium

Beyond the preview

Go deeper on NCT02431598.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02431598.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call